论文部分内容阅读
Serum concentrations of tissue polypeptidespecific antigen (TPS) and Cytokeratin-19-Fragments (CYFRA 21-1) before operation or chemotherapy have been proved to be a useful prognostic tool for patients with NSCLC, but the related data for advanced NSCLC patientstreated with gefitinib are limited.